Concurrent ChemoRadiation (CCR) is better than Accelerated Radiation Alone (ARA) in Patients with Moderate Advanced Head and Neck Squamous Cell Carcinoma (MAHNSCC). Mature results of HN08 Polish Trial

Literature data of locally advanced HNC treatment confirm one week accelerated radiation could be biological equivalent to one course of high dose cisplatin given concurrently with conventional radiation. We have wondered if in less (moderately) advanced HNC patients ARA could replace the toxic CCR. This is report of long term outcomes of CCR and ARA of patients treated in MSC Cancer Centre and Institute in Gliwice over 2008-2013 within randomised clinical trial (HN08 PT).